Denmark: CagriSema has demonstrated superior weight loss in adults with obesity or overweight and type 2 diabetes in the ...

Wearable and implantable biosensors that can accurately detect biological molecules in a non- or minimally invasive manner ...

Novo Nordisk (NVO) stock rebounds after Kepler Cheuvreux upgrades to Buy following a 42% stock drop over the past year. Read ...

European shares experienced gains driven mainly by healthcare stocks, despite fears of an escalating U.S.-EU trade war. The ...

Professor Julia Vorholt's work has changed how we think about plant health. Her innovative research on plant microbiomes holds the potential to transform agriculture. For her achievements, the ...

European markets are expected to open in mixed territory Thursday, stumbling lower as President Donald Trump’s tariffs policy upends global trading relations.

Roche and Zealand reason petrelintide could deliver weight loss comparable to glucagon-like peptide 1 (GLP-1) receptor ...

Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for ...

Swiss drugmaker Roche on Wednesday announced a major deal in the weight-loss category, agreeing to pay up to $5.3 billion to Zealand Pharma in a licensing and development agreement. Zealand Pharma's ...

WASHINGTON (Reuters) -President Donald Trump's nominee to lead the agency overseeing Medicare should divest financial ties to healthcare and pharmaceutical companies that could benefit from his policy ...

Roche is paying $1.65 billion in confirmed upfront fees to add to its burgeoning obesity pipelin | Roche is paying $1.65 ...

Uncertainty around President Donald Trump’s tariff policies have sent the major averages on a roller-coaster ride and spurred ...